+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

From
Plasma Therapy Global Market Report 2024 - Product Thumbnail Image

Plasma Therapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Blood Coagulation Factor Activators - Pipeline Insight, 2024 - Product Thumbnail Image

Blood Coagulation Factor Activators - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Plasma Therapeutics Market 2022-2026 - Product Thumbnail Image

Plasma Therapeutics Market 2022-2026

  • Report
  • April 2022
  • 120 Pages
  • Global
From
Convalescent Plasma Therapy Global Market Report 2024 - Product Thumbnail Image

Convalescent Plasma Therapy Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
From
From
From
Hypofibrinogenemia - Pipeline Insight, 2024 - Product Thumbnail Image

Hypofibrinogenemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Loading Indicator